Clinical utility of ramucirumab in non-small-cell lung cancer

par Uprety D
Publié 2019

New targeted treatments for non-small-cell lung cancer – role of nivolumab

par Zago G, Muller M, van den Heuvel M, Baas P
Publié 2016

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China

par Anwen Xiong, Jiali Wang, Caicun Zhou
Publié 2021

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

par Garcia-Valdecasas Gayo Sonsoles, Ruiz-Alvarez Maria Jesus, Gonzalez-Gay Daniel, Ramos-Corral Raquel, Marquez-Lietor Eva, Del Amo Nazaret, Plata Maria del Carmen, Guillén-Santos Raquel, Arribas Ignacio, Cava-Valenciano Fernando
Publié 2020

Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation

par Boning Cai, Xiaomo Li, Xiang Huang, Tonghui Ma, Baolin Qu, Wei Yu, Wei Yang, Pei Zhang, Jing Chen, Fang Liu
Publié 2021

AKF-D52, a Synthetic Phenoxypyrimidine-Urea Derivative, Triggers Extrinsic/Intrinsic Apoptosis and Cytoprotective Autophagy in Human Non-Small Cell Lung Cancer Cells

par Hyo-Sun Gil, Jeong-Hun Lee, Ahmed K. Farag, Ahmed H. E. Hassan, Kyung-Sook Chung, Jung-Hye Choi, Eun-Joo Roh, Kyung-Tae Lee
Publié 2021

Safety and Feasibility of Video-Assisted Thoracoscopic Day Surgery and Inpatient Surgery in Patients With Non-small Cell Lung Cancer: A Single-Center Retrospective Cohort Study

par Yingxian Dong, Cheng Shen, Yan Wang, Kun Zhou, Jue Li, Shuai Chang, Hongsheng Ma, Guowei Che
Publié 2021

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study

par Khan M, Zhao Z, Li X, Liao G
Publié 2021

Circular RNA SMARCA5 Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer by miR-19b-3p/HOXA9 Axis [Retraction]

par Wang Y, Li H, Lu H, Qin Y
Publié 2021

Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib

par Mengqiu Tang, Chao Song, Yaowen Zhang, Xiaoyu Xu, Chen Wang, Zhanchun Zhang, Tian Chen
Publié 2021

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

par Gan J, Huang Y, Liao J, Pang L, Fang W
Publié 2021

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients

par Olga V. Pankova, Liubov A. Tashireva, Evgeny O. Rodionov, Sergey V. Miller, Sergey A. Tuzikov, Dmitry S. Pismenny, Tatiana S. Gerashchenko, Marina V. Zavyalova, Marina V. Zavyalova, Sergey V. Vtorushin, Sergey V. Vtorushin, Evgeny V. Denisov, Evgeny V. Denisov, Vladimir M. Perelmuter
Publié 2021

Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer

par Cristina Minnelli, Laura Cianfruglia, Emiliano Laudadio, Giovanna Mobbili, Roberta Galeazzi, Tatiana Armeni
Publié 2021

Clinical Practice of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Targeted Drugs Combined with Gadolinium Oxide Nanoparticles in the Treatment of Non-Small Cell Lung...

par Xuan Zhou, Ting Jin, Likun Wang, Erlin Zhao, Xuyang Xiao
Publié 2021